The State of Texas Attorney General Files Lawsuit Against Acetaminophen Producers Concerning Autism Spectrum Claims

The top legal official in Texas Ken Paxton is taking legal action against the manufacturers of acetaminophen, asserting the corporations hid potential risks that the medication created to pediatric cognitive development.

This legal action arrives a month after President Donald Trump publicized an unverified association between using Tylenol - referred to as acetaminophen - during pregnancy and autism in children.

Paxton is taking legal action against the pharmaceutical giant, which formerly manufactured the drug, the only pain reliever approved for expectant mothers, and the current manufacturer, which presently makes it.

In a statement, he stated they "deceived the public by gaining financially from discomfort and pushing pills regardless of the risks."

The company states there is lacking scientific proof linking acetaminophen to autism spectrum disorder.

"These corporations misled for generations, deliberately risking numerous people to boost earnings," the attorney general, a Republican, declared.

Kenvue stated officially that it was "seriously troubled by the dissemination of inaccurate information on the reliability of acetaminophen and the potential impact that could have on the welfare of US mothers and children."

On its official site, Kenvue also said it had "regularly reviewed the relevant science and there is lacking reliable evidence that demonstrates a proven link between using acetaminophen and autism."

Groups acting on behalf of medical professionals and health professionals concur.

The leading OB-GYN organization has declared acetaminophen - the primary component in acetaminophen - is among limited choices for expectant mothers to manage pain and elevated temperature, which can create serious health risks if left untreated.

"In more than two decades of studies on the utilization of paracetamol in pregnancy, zero credible investigations has definitively established that the usage of paracetamol in any period of gestation causes neurodevelopmental disorders in young ones," the association commented.

The lawsuit cites recent announcements from the former administration in asserting the drug is reportedly hazardous.

Recently, the former president raised alarms from health experts when he instructed expectant mothers to "fight like hell" not to take Tylenol when sick.

The FDA then released a statement that medical professionals should contemplate reducing the use of acetaminophen, while also mentioning that "a causal relationship" between the drug and autism spectrum disorder in young ones has not been established.

The Health Department head Kennedy, who manages the Food and Drug Administration, had pledged in spring to initiate "extensive scientific investigation" that would identify the origin of autism in a matter of months.

But specialists advised that identifying a sole reason of autism spectrum disorder - thought by researchers to be the outcome of a complicated interplay of genetic and surrounding conditions - would prove challenging.

Autism spectrum disorder is a type of permanent neurological difference and condition that impacts how people perceive and relate to the environment, and is diagnosed using physician assessments.

In his lawsuit, the attorney general - a Trump ally who is seeking federal office - asserts the manufacturer and J&J "deliberately disregarded and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

The case attempts to require the firms "eliminate any promotional materials" that asserts acetaminophen is reliable for women during pregnancy.

This legal action parallels the grievances of a group of guardians of children with autism and attention deficit hyperactivity disorder who took legal action against the makers of acetaminophen in two years ago.

A federal judge dismissed the legal action, saying research from the family's specialists was not conclusive.